Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DDAVP for post-operative ecchymosis in rhinoplasty
NCT01982760Phase 2Terminated
- Sponsor
- University Hospitals Cleveland Medical Center
- Start
- Dec 2013
- Primary completion
- Jun 2015
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of desmopressin in ecchymosis, sponsored by University Hospitals Cleveland Medical Center. Primary endpoint: Reduction in Ecchymosis and Swelling at 8 days. Started Dec 2013; status: terminated.
02
Drugs
desmopressin
03
Conditions
ecchymosis
Beyond the preview
Go deeper on NCT01982760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01982760.